HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aubrey Capital Management Ltd 11,199$403,9480.26%
Knights of Columbus Asset Advisors LLC 79,941$2,883,4720.26%
SCOUT INVESTMENTS, INC. 273,298$11,956,7870.24%
CABOT WEALTH MANAGEMENT INC 44,355$1,6000.24%
DRIEHAUS CAPITAL MANAGEMENT LLC 518,957$18,718,7790.24%
Virtus ETF Advisers LLC 10,422$375,9220.22%
Virtus Investment Advisers, Inc. 8,579$309,4450.21%
Virtus Fund Advisers, LLC 750$27,0530.19%
Bayesian Capital Management, LP 46,100$1,662,8270.18%
THRIVENT FINANCIAL FOR LUTHERANS 2,078,838$74,9840.17%
MARSHALL WACE, LLP 2,323,523$83,809,4760.16%
TORRAY INVESTMENT PARTNERS LLC 24,959$900,2710.16%
Woodline Partners LP 346,555$12,500,2390.15%
OAK HILL WEALTH ADVISORS, LLC 12,500$450,8750.14%
NJ State Employees Deferred Compensation Plan 27,800$1,002,7460.14%
MACQUARIE GROUP LTD 3,309,355$119,368,0000.14%
Bison Wealth, LLC 20,043$722,9510.13%
SILVERCREST ASSET MANAGEMENT GROUP LLC 516,170$18,618,2520.13%
Samalin Investment Counsel, LLC 6,637$239,3970.13%
EAGLE ASSET MANAGEMENT INC 587,073$21,175,7230.12%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.